| MeSH term | MeSH ID | Detail |
|---|---|---|
| Spondylarthropathies | D025242 | 1 associated lipids |
| Legg-Calve-Perthes Disease | D007873 | 1 associated lipids |
| Chondrocalcinosis | D002805 | 1 associated lipids |
| Lymphangioleiomyomatosis | D018192 | 1 associated lipids |
| Carcinoid Heart Disease | D002275 | 1 associated lipids |
| Alphavirus Infections | D018354 | 1 associated lipids |
| Jaw, Edentulous | D007575 | 1 associated lipids |
| Foot Injuries | D018409 | 1 associated lipids |
| Synovitis, Pigmented Villonodular | D013586 | 1 associated lipids |
| Periostitis | D010522 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Guzel S et al. | Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. | 2013 | Diab Vasc Dis Res | pmid:22496403 |
| Tao H et al. | OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. | 2013 | Cardiology | pmid:23751957 |
| Xi L et al. | OPG/RANK/RANKL axis in atrial fibrillation. | 2013 | Cardiology | pmid:23752030 |
| Ostrowska Z et al. | Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. | 2013 | Postepy Hig Med Dosw (Online) | pmid:23752595 |
| Uehara H et al. | Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. | 2013 | Int. J. Oncol. | pmid:23708710 |
| Luo J et al. | 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. | 2013 | Biomed Res Int | pmid:23710436 |
| Zhu Y et al. | Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. | 2013 | J. Cell. Physiol. | pmid:22674471 |
| Neunaber C et al. | Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. | 2013 | Injury | pmid:23773407 |
| Hakimi M et al. | The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. | 2013 | Int. J. Mol. Med. | pmid:23722820 |
| Marshall AJ et al. | Long-chain triazolyl acids as inhibitors of osteoclastogenesis. | 2013 | Bioorg. Med. Chem. | pmid:23726411 |
| Brzóska MM and Rogalska J | Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. | 2013 | Toxicol. Appl. Pharmacol. | pmid:23726800 |
| Van Schepdael A et al. | A mechanobiological model of orthodontic tooth movement. | 2013 | Biomech Model Mechanobiol | pmid:22539046 |
| Kim J et al. | Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. | 2013 | Clin. Biochem. | pmid:23726804 |
| Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
| Albu A et al. | Bone metabolism regulators and arterial stiffness in postmenopausal women. | 2013 | Maturitas | pmid:23916080 |
| Bauer S et al. | Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. | 2013 | Epilepsy Res. | pmid:23916144 |
| Nile CJ et al. | Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. | 2013 | J. Clin. Periodontol. | pmid:23919740 |
| Kim HR et al. | The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. | 2013 | Nephron Clin Pract | pmid:23921088 |
| O'Sullivan EP et al. | A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. | 2013 | Metab. Clin. Exp. | pmid:22841521 |
| Steensma MR et al. | Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. | 2013 | PLoS ONE | pmid:23922683 |
| Czyzewska-Buczyńska A et al. | [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients]. | 2013 | Prz. Lek. | pmid:24003660 |
| Fathilah SN et al. | Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model. | 2013 | BMC Complement Altern Med | pmid:24007208 |
| Einvik G et al. | Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. | 2013 | J Affect Disord | pmid:22862888 |
| Koufany M et al. | The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. | 2013 | Arthritis Rheum. | pmid:23982996 |
| Mozzati M et al. | Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. | 2013 | Clin Oral Investig | pmid:22864527 |
| Benito-Martin A et al. | Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. | 2013 | PLoS ONE | pmid:24058411 |
| Lau CP et al. | Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. | 2013 | Connect. Tissue Res. | pmid:24060052 |
| Corrado A et al. | RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. | 2013 | J. Rheumatol. | pmid:23457386 |
| Koluman BU et al. | Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. | 2013 | Clin. Nephrol. | pmid:23458176 |
| Wang J et al. | Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. | 2013 | Med. Hypotheses | pmid:24074896 |
| Kuo PL et al. | MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. | 2013 | Biochim. Biophys. Acta | pmid:23458685 |
| Li F et al. | Effect of parathyroid hormone on experimental tooth movement in rats. | 2013 | Am J Orthod Dentofacial Orthop | pmid:24075660 |
| Sato K et al. | RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. | 2013 | Am. J. Pathol. | pmid:23499553 |
| Pneumaticos SG et al. | Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. | 2013 | Expert Opin. Ther. Targets | pmid:24024908 |
| Sooampon S et al. | Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. | 2013 | J. Periodont. Res. | pmid:22587561 |
| Matuszewski Å et al. | Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. | 2013 | Int Orthop | pmid:23503639 |
| Tarantino U et al. | A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab. | 2013 | Aging Clin Exp Res | pmid:24046047 |
| Galli C et al. | GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. | 2013 | Clin Oral Implants Res | pmid:22626030 |
| Albers J et al. | Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. | 2013 | J. Cell Biol. | pmid:23401003 |
| Nahidi L et al. | Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. | 2013 | Dig. Dis. Sci. | pmid:24048682 |
| Hope S et al. | Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. | 2013 | Schizophr. Res. | pmid:23403415 |
| Thormann U et al. | Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. | 2013 | Biomaterials | pmid:23906515 |
| D'Amico L et al. | Bone metastases in gastric cancer follow a RANKL-independent mechanism. | 2013 | Oncol. Rep. | pmid:23404437 |
| Lekesiz K et al. | Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. | 2013 | Folia Histochem. Cytobiol. | pmid:23907946 |
| Briana DD et al. | Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies. | 2013 | J. Matern. Fetal. Neonatal. Med. | pmid:23406471 |
| McDonald MM et al. | Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity. | 2013 | J. Bone Miner. Res. | pmid:23408642 |
| CalderÃn S et al. | Short-term clinical and osteoimmunological effects of scaling and root planing complemented by simple or repeated laser phototherapy in chronic periodontitis. | 2013 | Lasers Med Sci | pmid:22546942 |
| Mogi M and Kondo A | The presence of RANKL-OPG complex in human osteosarcoma U2OS. | 2013 | J Immunoassay Immunochem | pmid:23859786 |
| Zappitelli T et al. | The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. | 2013 | J. Bone Miner. Res. | pmid:23606335 |
| Kao SY et al. | Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. | 2013 | Neurobiol. Dis. | pmid:23607938 |
| Wu M et al. | Vascular calcification: an update on mechanisms and challenges in treatment. | 2013 | Calcif. Tissue Int. | pmid:23456027 |
| Venojärvi M et al. | 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. | 2013 | Food Chem. Toxicol. | pmid:23623841 |
| Kitamura K et al. | Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. | 2013 | Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. | pmid:23632157 |
| Shen L et al. | Association between osteoprotegerin genetic variants and bone mineral density in Chinese women. | 2013 | Int. Immunopharmacol. | pmid:23619553 |
| Xie GQ et al. | Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women. | 2013 | Clin. Chim. Acta | pmid:23643930 |
| Aranha AM et al. | Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. | 2013 | J Endod | pmid:23228262 |
| Ding CZ et al. | [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:23646485 |
| Jiang S et al. | Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. | 2013 | Poult. Sci. | pmid:23687138 |
| Brabnikova Maresova K et al. | Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. | 2013 | Calcif. Tissue Int. | pmid:23247536 |
| Eren MA et al. | Association of parity with osteoprotegerin levels and atherosclerosis. | 2013 | Arch. Gynecol. Obstet. | pmid:23287888 |
| Kim SJ et al. | Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. | 2013 | Arch. Oral Biol. | pmid:23219295 |
| Kanzaki H et al. | Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. | 2013 | Exp. Mol. Pathol. | pmid:23219833 |
| Kim J et al. | Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. | 2013 | J. Bone Miner. Res. | pmid:23633269 |
| Wang H et al. | Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. | 2013 | Gene Ther. | pmid:22318091 |
| Hussien YM et al. | Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. | 2013 | Mol. Biol. Rep. | pmid:23271131 |
| Tetè S et al. | Maxillary sinus augmentation procedures through equine-derived biomaterial or calvaria autologous bone: immunohistochemical evaluation of OPG/RANKL in humans. | 2013 | Eur J Histochem | pmid:23549459 |
| Kuang B et al. | Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273362 |
| Matsuzaki E et al. | Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. | 2013 | Bone | pmid:23612487 |
| Flórez-Moreno GA et al. | Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273364 |
| Hyseni A et al. | Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. | 2013 | Thromb. Res. | pmid:23273402 |
| Engvall IL et al. | Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. | 2013 | Rheumatology (Oxford) | pmid:23275387 |
| Ko GJ | A biomarker, osteoprotegerin, in patients undergoing hemodialysis. | 2013 | Korean J. Intern. Med. | pmid:24307839 |
| Lee JE et al. | Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. | 2013 | Korean J. Intern. Med. | pmid:24307842 |
| Hartwich JE et al. | Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model. | 2013 | J. Pediatr. Surg. | pmid:23331792 |
| Naidu VG et al. | RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. | 2013 | Chem. Biol. Interact. | pmid:23333834 |
| Zhang Q et al. | Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. | 2013 | ScientificWorldJournal | pmid:24222748 |
| Yao Y et al. | Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. | 2013 | Rheumatol. Int. | pmid:23334376 |
| Luo ZR et al. | [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. | 2013 | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | pmid:24225213 |
| Zhang F et al. | Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. | 2013 | Med. Oncol. | pmid:23335067 |
| Tisato V et al. | GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. | 2013 | Mediators Inflamm. | pmid:24327798 |
| Su SJ et al. | Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. | 2013 | Int J Food Sci Nutr | pmid:23301724 |
| Aoki A et al. | Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. | 2013 | Cardiovasc Diabetol | pmid:23302066 |
| Pathan E et al. | Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. | 2013 | Ann. Rheum. Dis. | pmid:22984171 |
| Ambroszkiewicz J et al. | Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis. | 2013 | Adv Med Sci | pmid:24277958 |
| Wong KC et al. | Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. | 2013 | Br. J. Nutr. | pmid:23302510 |
| Wada T | [RANKL inhibition in bone metastases]. | 2013 | Nippon Yakurigaku Zasshi | pmid:23302944 |
| Guerra-Menéndez L et al. | IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. | 2013 | J Transl Med | pmid:24161214 |
| Romagnoli C et al. | Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. | 2013 | FEBS J. | pmid:23176170 |
| Revu S et al. | Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. | 2013 | Arthritis Res. Ther. | pmid:24295447 |
| Kadkhodazadeh M et al. | Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. | 2013 | Arch. Oral Biol. | pmid:23177932 |
| Gutiérrez-Rojas I et al. | Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. | 2013 | Mol. Cell. Endocrinol. | pmid:23178165 |
| Barbieri G et al. | Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. | 2013 | Angle Orthod | pmid:22716279 |
| Bolzoni M et al. | Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. | 2013 | Exp. Hematol. | pmid:23178378 |
| Lee MH et al. | The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. | 2013 | Arch. Oral Biol. | pmid:22717323 |
| Dalcico R et al. | Protective mechanisms of simvastatin in experimental periodontal disease. | 2013 | J. Periodontol. | pmid:23181416 |
| Balani D et al. | Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. | 2013 | Arthritis Rheum. | pmid:23124514 |
| Mercatali L et al. | RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. | 2013 | Int J Mol Sci | pmid:23702841 |
| Braun T et al. | Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. | 2013 | J. Bone Miner. Res. | pmid:23169443 |
| Rivadeneira F | Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. | 2013 | Endocrine | pmid:23001603 |
| Scott JP et al. | Effect of recovery duration between two bouts of running on bone metabolism. | 2013 | Med Sci Sports Exerc | pmid:23034642 |